REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Laboratorios Pharmek S A S (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Laboratorios Pharmek S A S Profile Updated: July 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Laboratorios Pharmek S A S is an enterprise based in Colombia. Its main office is in Bogota D.C.. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was established on January 25, 2001. 6 (2025) employees currently work for Laboratorios Pharmek S A S. In 2025, the company reported a net sales revenue increase of 67.74%. Its’ total assets recorded a growth of 11.2%.

Headquarters
Cll 134 D # 52 A 26
Bogota D.C.; Bogota D.C; Postal Code: 1019

Contact Details: Purchase the Laboratorios Pharmek S A S report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorios Pharmek S A S report to view the information.
Financial Auditors:
Purchase the Laboratorios Pharmek S A S report to view the information.
Incorporation Date:
January 25, 2001
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Company Performance
Financial values in the chart are available after Laboratorios Pharmek S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
67.74%▲
Total Operating Revenue
67.74%▲
Operating Profit
1632.14%▲
Total Assets
11.2%▲
Total Equity
27.35%▲
Operating Profit Margin
10.91%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo